Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 178 entries
Sorted by: Best Match Show Resources per page
Glucosinolate-derived isothiocyanates impact mitochondrial function in fungal cells and elicit an oxidative stress response necessary for growth recovery.

Frontiers in plant science

Calmes B, N'Guyen G, Dumur J, Brisach CA, Campion C, Iacomi B, Pigné S, Dias E, Macherel D, Guillemette T, Simoneau P.
PMID: 26089832
Front Plant Sci. 2015 Jun 03;6:414. doi: 10.3389/fpls.2015.00414. eCollection 2015.

Glucosinolates are brassicaceous secondary metabolites that have long been considered as chemical shields against pathogen invasion. Isothiocyanates (ITCs), are glucosinolate-breakdown products that have negative effects on the growth of various fungal species. We explored the mechanism by which ITCs...

Cite
Calmes B, N'Guyen G, Dumur J, et al. Glucosinolate-derived isothiocyanates impact mitochondrial function in fungal cells and elicit an oxidative stress response necessary for growth recovery. Front Plant Sci. 2015;6:414doi: 10.3389/fpls.2015.00414.
Calmes, B., N'Guyen, G., Dumur, J., Brisach, C. A., Campion, C., Iacomi, B., Pigné, S., Dias, E., Macherel, D., Guillemette, T., & Simoneau, P. (2015). Glucosinolate-derived isothiocyanates impact mitochondrial function in fungal cells and elicit an oxidative stress response necessary for growth recovery. Frontiers in plant science, 6414. https://doi.org/10.3389/fpls.2015.00414
Calmes, Benoit, et al. "Glucosinolate-derived isothiocyanates impact mitochondrial function in fungal cells and elicit an oxidative stress response necessary for growth recovery." Frontiers in plant science vol. 6 (2015): 414. doi: https://doi.org/10.3389/fpls.2015.00414
Calmes B, N'Guyen G, Dumur J, Brisach CA, Campion C, Iacomi B, Pigné S, Dias E, Macherel D, Guillemette T, Simoneau P. Glucosinolate-derived isothiocyanates impact mitochondrial function in fungal cells and elicit an oxidative stress response necessary for growth recovery. Front Plant Sci. 2015 Jun 03;6:414. doi: 10.3389/fpls.2015.00414. eCollection 2015. PMID: 26089832; PMCID: PMC4452805.
Copy Download .nbib Format: NLM
Does core mobility of lumbar total disc arthroplasty influence sagittal and frontal intervertebral displacement? Radiologic comparison with fixed-core prosthesis.

SAS journal

Delécrin J, Allain J, Beaurain J, Steib JP, Chataigner H, Aubourg L, Huppert J, Ameil M, Nguyen JM.
PMID: 25802632
SAS J. 2009 Sep 01;3(3):91-9. doi: 10.1016/j.esas.2009.09.001. eCollection 2009.

BACKGROUND: An artificial disc prosthesis is thought to restore segmental motion in the lumbar spine. However, it is reported that disc prosthesis can increase the intervertebral translation (VT). The concept of the mobile-core prosthesis is to mimic the kinematic...

Cite
Delécrin J, Allain J, Beaurain J, et al. Does core mobility of lumbar total disc arthroplasty influence sagittal and frontal intervertebral displacement? Radiologic comparison with fixed-core prosthesis. SAS J. 2009;3(3):91-9doi: 10.1016/j.esas.2009.09.001.
Delécrin, J., Allain, J., Beaurain, J., Steib, J. P., Chataigner, H., Aubourg, L., Huppert, J., Ameil, M., & Nguyen, J. M. (2009). Does core mobility of lumbar total disc arthroplasty influence sagittal and frontal intervertebral displacement? Radiologic comparison with fixed-core prosthesis. SAS journal, 3(3), 91-9. https://doi.org/10.1016/j.esas.2009.09.001
Delécrin, Joël, et al. "Does core mobility of lumbar total disc arthroplasty influence sagittal and frontal intervertebral displacement? Radiologic comparison with fixed-core prosthesis." SAS journal vol. 3,3 (2009): 91-9. doi: https://doi.org/10.1016/j.esas.2009.09.001
Delécrin J, Allain J, Beaurain J, Steib JP, Chataigner H, Aubourg L, Huppert J, Ameil M, Nguyen JM. Does core mobility of lumbar total disc arthroplasty influence sagittal and frontal intervertebral displacement? Radiologic comparison with fixed-core prosthesis. SAS J. 2009 Sep 01;3(3):91-9. doi: 10.1016/j.esas.2009.09.001. eCollection 2009. PMID: 25802632; PMCID: PMC4365600.
Copy Download .nbib Format: NLM
0.5% levobupivacaine versus 0.5% ropivacaine: Are they different in ultrasound-guided sciatic block?.

Saudi journal of anaesthesia

Pham Dang C, Langlois C, Lambert C, Nguyen JM, Asehnoune K, Lejus C.
PMID: 25558190
Saudi J Anaesth. 2015 Jan;9(1):3-8. doi: 10.4103/1658-354X.146250.

CONTEXT AND AIMS: Little is known about onset and duration of sciatic block after 0.5% levobupivacaine (Levo) versus 0.5% ropivacaine (Ropi) for ultrasound-guided technique. We assessed these parameters in the ultrasound-guided block, to know for the practice.SETTING AND DESIGN:...

Cite
Pham Dang C, Langlois C, Lambert C, et al. 0.5% levobupivacaine versus 0.5% ropivacaine: Are they different in ultrasound-guided sciatic block?. Saudi J Anaesth. 2015;9(1):3-8doi: 10.4103/1658-354X.146250.
Pham Dang, C., Langlois, C., Lambert, C., Nguyen, J. M., Asehnoune, K., & Lejus, C. (2015). 0.5% levobupivacaine versus 0.5% ropivacaine: Are they different in ultrasound-guided sciatic block?. Saudi journal of anaesthesia, 9(1), 3-8. https://doi.org/10.4103/1658-354X.146250
Pham Dang, Charles, et al. "0.5% levobupivacaine versus 0.5% ropivacaine: Are they different in ultrasound-guided sciatic block?." Saudi journal of anaesthesia vol. 9,1 (2015): 3-8. doi: https://doi.org/10.4103/1658-354X.146250
Pham Dang C, Langlois C, Lambert C, Nguyen JM, Asehnoune K, Lejus C. 0.5% levobupivacaine versus 0.5% ropivacaine: Are they different in ultrasound-guided sciatic block?. Saudi J Anaesth. 2015 Jan;9(1):3-8. doi: 10.4103/1658-354X.146250. PMID: 25558190; PMCID: PMC4279346.
Copy Download .nbib Format: NLM
Construction of an instrument for measuring medical student satisfaction with virtual campus.

Studies in health technology and informatics

El Balaa Z, Philippe HJ, Volteau C, le Beux P, Nguyen JM.
PMID: 16160372
Stud Health Technol Inform. 2005;116:897-902.

In France, the virtual campus became a pedagogical tool used in the medical education in year 2000. Therefore, it is appropriate to measure the student satisfaction, user of virtual campus. The objective of this research was to develop a...

Cite
El Balaa Z, Philippe HJ, Volteau C, et al. Construction of an instrument for measuring medical student satisfaction with virtual campus. Stud Health Technol Inform. 2005;116:897-902
El Balaa, Z., Philippe, H. J., Volteau, C., le Beux, P., & Nguyen, J. M. (2005). Construction of an instrument for measuring medical student satisfaction with virtual campus. Studies in health technology and informatics, 116897-902.
El Balaa, Ziad, et al. "Construction of an instrument for measuring medical student satisfaction with virtual campus." Studies in health technology and informatics vol. 116 (2005): 897-902.
El Balaa Z, Philippe HJ, Volteau C, le Beux P, Nguyen JM. Construction of an instrument for measuring medical student satisfaction with virtual campus. Stud Health Technol Inform. 2005;116:897-902. PMID: 16160372.
Copy Download .nbib Format: NLM
A multiscale microstructure model of carbon black distribution in rubber.

Journal of microscopy

Jean A, Jeulin D, Forest S, Cantournet S, N'guyen F.
PMID: 21118222
J Microsc. 2011 Mar;241(3):243-60. doi: 10.1111/j.1365-2818.2010.03428.x. Epub 2010 Oct 13.

The increase of observations and computational capabilities favoured the numerical simulation of microstructure to derive the effective properties of materials. Indeed, the multiscale approaches, that use homogenization techniques, enable us to estimate or to give bounds of the overall...

Cite
Jean A, Jeulin D, Forest S, et al. A multiscale microstructure model of carbon black distribution in rubber. J Microsc. 2010;241(3):243-60doi: 10.1111/j.1365-2818.2010.03428.x.
Jean, A., Jeulin, D., Forest, S., Cantournet, S., & N'guyen, F. (2011). A multiscale microstructure model of carbon black distribution in rubber. Journal of microscopy, 241(3), 243-60. https://doi.org/10.1111/j.1365-2818.2010.03428.x
Jean, A, et al. "A multiscale microstructure model of carbon black distribution in rubber." Journal of microscopy vol. 241,3 (2011): 243-60. doi: https://doi.org/10.1111/j.1365-2818.2010.03428.x
Jean A, Jeulin D, Forest S, Cantournet S, N'guyen F. A multiscale microstructure model of carbon black distribution in rubber. J Microsc. 2011 Mar;241(3):243-60. doi: 10.1111/j.1365-2818.2010.03428.x. Epub 2010 Oct 13. PMID: 21118222.
Copy Download .nbib Format: NLM
Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung Cancer.

Cell & developmental biology

Wangpaichitr M, Kandemir H, Li YY, Wu C, Nguyen D, Feun LG, Kuo MT, Savaraj N.
PMID: 28819582
Cell Dev Biol. 2017 Jun;6(2). doi: 10.4172/2168-9296.1000183. Epub 2017 Apr 28.

Despite numerous reports on immune checkpoint inhibitor for the treatment of non-small cell lung cancer (NSCLC), the response rate remains low but durable. Thus cisplatin still plays a major role in the treatment of NSCLC. While there are many...

Cite
Wangpaichitr M, Kandemir H, Li YY, et al. Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung Cancer. Cell Dev Biol. 2017;6(2)doi: 10.4172/2168-9296.1000183.
Wangpaichitr, M., Kandemir, H., Li, Y. Y., Wu, C., Nguyen, D., Feun, L. G., Kuo, M. T., & Savaraj, N. (2017). Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung Cancer. Cell & developmental biology, 6(2), . https://doi.org/10.4172/2168-9296.1000183
Wangpaichitr, M, et al. "Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung Cancer." Cell & developmental biology vol. 6,2 (2017). doi: https://doi.org/10.4172/2168-9296.1000183
Wangpaichitr M, Kandemir H, Li YY, Wu C, Nguyen D, Feun LG, Kuo MT, Savaraj N. Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung Cancer. Cell Dev Biol. 2017 Jun;6(2). doi: 10.4172/2168-9296.1000183. Epub 2017 Apr 28. PMID: 28819582; PMCID: PMC5557290.
Copy Download .nbib Format: NLM
Diagnostic Performances of Urinary Methylmalonic Acid/Creatinine Ratio in Vitamin B12 Deficiency.

Journal of clinical medicine

Supakul S, Chabrun F, Genebrier S, N'Guyen M, Valarche G, Derieppe A, Villoteau A, Lacombe V, Urbanski G.
PMID: 32707915
J Clin Med. 2020 Jul 22;9(8). doi: 10.3390/jcm9082335.

Sole measurement of plasma vitamin B12 is no longer enough to identify vitamin B12 (B12) deficiency. When plasma vitamin B12 is in the low-normal range, especially between 201 and 350 ng/L, B12 deficiency should be assessed by measurements of...

Cite
Supakul S, Chabrun F, Genebrier S, et al. Diagnostic Performances of Urinary Methylmalonic Acid/Creatinine Ratio in Vitamin B12 Deficiency. J Clin Med. 2020;9(8)doi: 10.3390/jcm9082335.
Supakul, S., Chabrun, F., Genebrier, S., N'Guyen, M., Valarche, G., Derieppe, A., Villoteau, A., Lacombe, V., & Urbanski, G. (2020). Diagnostic Performances of Urinary Methylmalonic Acid/Creatinine Ratio in Vitamin B12 Deficiency. Journal of clinical medicine, 9(8), . https://doi.org/10.3390/jcm9082335
Supakul, Sopak, et al. "Diagnostic Performances of Urinary Methylmalonic Acid/Creatinine Ratio in Vitamin B12 Deficiency." Journal of clinical medicine vol. 9,8 (2020). doi: https://doi.org/10.3390/jcm9082335
Supakul S, Chabrun F, Genebrier S, N'Guyen M, Valarche G, Derieppe A, Villoteau A, Lacombe V, Urbanski G. Diagnostic Performances of Urinary Methylmalonic Acid/Creatinine Ratio in Vitamin B12 Deficiency. J Clin Med. 2020 Jul 22;9(8). doi: 10.3390/jcm9082335. PMID: 32707915; PMCID: PMC7466029.
Copy Download .nbib Format: NLM
A Lagerstätte from Australia provides insight into the nature of Miocene mesic ecosystems.

Science advances

McCurry MR, Cantrill DJ, Smith PM, Beattie R, Dettmann M, Baranov V, Magee C, Nguyen JMT, Forster MA, Hinde J, Pogson R, Wang H, Marjo CE, Vasconcelos P, Frese M.
PMID: 34995110
Sci Adv. 2022 Jan 07;8(1):eabm1406. doi: 10.1126/sciadv.abm1406. Epub 2022 Jan 07.

[Figure: see text].

Cite
McCurry MR, Cantrill DJ, Smith PM, et al. A Lagerstätte from Australia provides insight into the nature of Miocene mesic ecosystems. Sci Adv. 2022;8(1):eabm1406doi: 10.1126/sciadv.abm1406.
McCurry, M. R., Cantrill, D. J., Smith, P. M., Beattie, R., Dettmann, M., Baranov, V., Magee, C., Nguyen, J. M. T., Forster, M. A., Hinde, J., Pogson, R., Wang, H., Marjo, C. E., Vasconcelos, P., & Frese, M. (2022). A Lagerstätte from Australia provides insight into the nature of Miocene mesic ecosystems. Science advances, 8(1), eabm1406. https://doi.org/10.1126/sciadv.abm1406
McCurry, Matthew R, et al. "A Lagerstätte from Australia provides insight into the nature of Miocene mesic ecosystems." Science advances vol. 8,1 (2022): eabm1406. doi: https://doi.org/10.1126/sciadv.abm1406
McCurry MR, Cantrill DJ, Smith PM, Beattie R, Dettmann M, Baranov V, Magee C, Nguyen JMT, Forster MA, Hinde J, Pogson R, Wang H, Marjo CE, Vasconcelos P, Frese M. A Lagerstätte from Australia provides insight into the nature of Miocene mesic ecosystems. Sci Adv. 2022 Jan 07;8(1):eabm1406. doi: 10.1126/sciadv.abm1406. Epub 2022 Jan 07. PMID: 34995110.
Copy Download .nbib Format: NLM
Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management.

Journal of the American Academy of Dermatology

Soenen A, Vourc'h M, Khammari A, Nguyen JM, Bossard C, Denis Musquer M, Vergier B, Dréno B.
PMID: 33785385
J Am Acad Dermatol. 2021 Mar 27; doi: 10.1016/j.jaad.2021.03.077. Epub 2021 Mar 27.

BACKGROUND: Treatment of lentigo maligna (LM) is challenging because of the potential functional and esthetic surgical sequelae. Imiquimod has been proposed as a treatment for LM. Reflectance confocal microscopy (RCM) is a noninvasive method for the diagnosis of LM...

Cite
Soenen A, Vourc'h M, Khammari A, et al. Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management. J Am Acad Dermatol. 2021;doi: 10.1016/j.jaad.2021.03.077.
Soenen, A., Vourc'h, M., Khammari, A., Nguyen, J. M., Bossard, C., Denis Musquer, M., Vergier, B., & Dréno, B. (2021). Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management. Journal of the American Academy of Dermatology, . https://doi.org/10.1016/j.jaad.2021.03.077
Soenen, Anouk, et al. "Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management." Journal of the American Academy of Dermatology vol. (2021). doi: https://doi.org/10.1016/j.jaad.2021.03.077
Soenen A, Vourc'h M, Khammari A, Nguyen JM, Bossard C, Denis Musquer M, Vergier B, Dréno B. Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management. J Am Acad Dermatol. 2021 Mar 27; doi: 10.1016/j.jaad.2021.03.077. Epub 2021 Mar 27. PMID: 33785385.
Copy Download .nbib Format: NLM
Should Targeted Therapy Be Continued in BRAF-Mutant Melanoma Patients after Complete Remission?.

Dermatology (Basel, Switzerland)

Bédouelle E, Nguyen JM, Varey E, Khammari A, Dreno B.
PMID: 34818219
Dermatology. 2021 Oct 27;1-10. doi: 10.1159/000518718. Epub 2021 Oct 27.

BACKGROUND: Targeted therapy is used to treat patients with a BRAF-mutated metastatic melanoma and is continued until disease progression or severe toxicity. No robust data on the management of patients achieving a complete remission (CR) are available.MAIN OBJECTIVE: To...

Cite
Bédouelle E, Nguyen JM, Varey E, et al. Should Targeted Therapy Be Continued in BRAF-Mutant Melanoma Patients after Complete Remission?. Dermatology. 2021;1-10doi: 10.1159/000518718.
Bédouelle, E., Nguyen, J. M., Varey, E., Khammari, A., & Dreno, B. (2021). Should Targeted Therapy Be Continued in BRAF-Mutant Melanoma Patients after Complete Remission?. Dermatology (Basel, Switzerland), 1-10. https://doi.org/10.1159/000518718
Bédouelle, Eve, et al. "Should Targeted Therapy Be Continued in BRAF-Mutant Melanoma Patients after Complete Remission?." Dermatology (Basel, Switzerland) vol. (2021): 1-10. doi: https://doi.org/10.1159/000518718
Bédouelle E, Nguyen JM, Varey E, Khammari A, Dreno B. Should Targeted Therapy Be Continued in BRAF-Mutant Melanoma Patients after Complete Remission?. Dermatology. 2021 Oct 27;1-10. doi: 10.1159/000518718. Epub 2021 Oct 27. PMID: 34818219.
Copy Download .nbib Format: NLM
Role of VAMP7-Dependent Secretion of Reticulon 3 in Neurite Growth.

Cell reports

Wojnacki J, Nola S, Bun P, Cholley B, Filippini F, Pressé MT, Lipecka J, Man Lam S, N'guyen J, Simon A, Ouslimani A, Shui G, Fader CM, Colombo MI, Guerrera IC, Galli T.
PMID: 33357422
Cell Rep. 2020 Dec 22;33(12):108536. doi: 10.1016/j.celrep.2020.108536.

VAMP7 is involved in autophagy and in exocytosis-mediated neurite growth, two yet unconnected cellular pathways. Here, we find that nutrient restriction and activation of autophagy stimulate axonal growth, while autophagy inhibition leads to loss of neuronal polarity. VAMP7 knockout...

Cite
Wojnacki J, Nola S, Bun P, et al. Role of VAMP7-Dependent Secretion of Reticulon 3 in Neurite Growth. Cell Rep. 2020;33(12):108536doi: 10.1016/j.celrep.2020.108536.
Wojnacki, J., Nola, S., Bun, P., Cholley, B., Filippini, F., Pressé, M. T., Lipecka, J., Man Lam, S., N'guyen, J., Simon, A., Ouslimani, A., Shui, G., Fader, C. M., Colombo, M. I., Guerrera, I. C., & Galli, T. (2020). Role of VAMP7-Dependent Secretion of Reticulon 3 in Neurite Growth. Cell reports, 33(12), 108536. https://doi.org/10.1016/j.celrep.2020.108536
Wojnacki, José, et al. "Role of VAMP7-Dependent Secretion of Reticulon 3 in Neurite Growth." Cell reports vol. 33,12 (2020): 108536. doi: https://doi.org/10.1016/j.celrep.2020.108536
Wojnacki J, Nola S, Bun P, Cholley B, Filippini F, Pressé MT, Lipecka J, Man Lam S, N'guyen J, Simon A, Ouslimani A, Shui G, Fader CM, Colombo MI, Guerrera IC, Galli T. Role of VAMP7-Dependent Secretion of Reticulon 3 in Neurite Growth. Cell Rep. 2020 Dec 22;33(12):108536. doi: 10.1016/j.celrep.2020.108536. PMID: 33357422.
Copy Download .nbib Format: NLM
Facial trichoblastic carcinoma treated with Mohs micrographic surgery: A new indication for Mohs?.

JAAD case reports

Garcia A, Nguyen JM, Stetson CL, Tarbox MB.
PMID: 32509948
JAAD Case Rep. 2020 Jun 01;6(6):561-562. doi: 10.1016/j.jdcr.2020.02.004. eCollection 2020 Jun.

No abstract available.

Cite
Garcia A, Nguyen JM, Stetson CL, et al. Facial trichoblastic carcinoma treated with Mohs micrographic surgery: A new indication for Mohs?. JAAD Case Rep. 2020;6(6):561-562doi: 10.1016/j.jdcr.2020.02.004.
Garcia, A., Nguyen, J. M., Stetson, C. L., & Tarbox, M. B. (2020). Facial trichoblastic carcinoma treated with Mohs micrographic surgery: A new indication for Mohs?. JAAD case reports, 6(6), 561-562. https://doi.org/10.1016/j.jdcr.2020.02.004
Garcia, Andres, et al. "Facial trichoblastic carcinoma treated with Mohs micrographic surgery: A new indication for Mohs?." JAAD case reports vol. 6,6 (2020): 561-562. doi: https://doi.org/10.1016/j.jdcr.2020.02.004
Garcia A, Nguyen JM, Stetson CL, Tarbox MB. Facial trichoblastic carcinoma treated with Mohs micrographic surgery: A new indication for Mohs?. JAAD Case Rep. 2020 Jun 01;6(6):561-562. doi: 10.1016/j.jdcr.2020.02.004. eCollection 2020 Jun. PMID: 32509948; PMCID: PMC7265050.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 178 entries